Introduction: Eosinophilia (eosinophil fraction of leukocytes >5%), an indicative parameter for bioincompatibility in various circumstances, is well established in hemodialysis. However, change in eosinophil count (EOC) and its association with death-censored technique failure among peritoneal dialysis (PD) patients remain unclear. Methods: We compared eosinophils before and after PD initiation among 1,432 eligible continuous ambulatory PD patients regularly followed up in our PD center during 2007–2018. Risk factors of early-stage eosinophilia were examined by the logistic regression test. The relationship of early-stage eosinophilia and EOC with death-censored technique failure was examined using the Cox proportional hazards model for overall patients and for men and women separately. Results: After PD initiation, the EOC and percentage of patients with eosinophilia were significantly increased compared with baseline. Being male (odds ratio [OR]: 2.26; 95% confidence interval [CI]: 1.55–3.31; p < 0.001) and higher EOC at baseline (100 cells/μL increase, OR: 1.62; 95% CI: 1.45–1.82; p < 0.001) were risk factors of early-stage eosinophilia after PD initiation. During follow-up, 204 death-censored technique failures were recorded. In fully adjusted models, each with 100 cells/μL increase in EOC, the adjusted hazard ratios (HRs) of technique failure were 1.11 (95% CI: 1.03–1.20; p = 0.009) in the whole cohort, 1.29 (95% CI: 1.10–1.51; p = 0.002) in women, and 1.07 (95% CI: 0.97–1.17; p = 0.196) in men. Eosinophilia was significantly associated with the risk of technique failure for women (HR: 2.24; 95% CI: 1.07–4.70; p = 0.033), which was especially significant for women aged <55 years (HR: 7.61; 95% CI: 1.88–30.90; p = 0.005). Conclusion: EOC was increased significantly after PD initiation, and increased numbers of eosinophils were associated with higher death-censored technique failure in PD patients, especially women.

1.
Li
PK
,
Chow
KM
,
Van de Luijtgaarden
MW
,
Johnson
DW
,
Jager
KJ
,
Mehrotra
R
, et al.
Changes in the worldwide epidemiology of peritoneal dialysis
.
Nat Rev Nephrol
.
2017
;
13
(
2
):
90
103
.
2.
Yu
X
,
Yang
X
.
Peritoneal dialysis in China: meeting the challenge of chronic kidney failure
.
Am J Kidney Dis
.
2015
;
65
(
1
):
147
51
.
3.
Bechade
C
,
Guittet
L
,
Evans
D
,
Verger
C
,
Ryckelynck
JP
,
Lobbedez
T
.
Early failure in patients starting peritoneal dialysis: a competing risks approach
.
Nephrol Dial Transplant
.
2013
;
29
(
11
):
2127
35
.
4.
Simon
H-U
,
Yousefi
S
,
Germic
N
,
Arnold
IC
,
Haczku
A
,
Karaulov
AV
, et al.
The cellular functions of eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020
.
Int Arch Allergy Immunol
.
2020
;
181
(
1
):
11
23
.
5.
Togias
A
.
Systemic effects of local allergic disease
.
J Allergy Clin Immunol
.
2004
;
113
(
1 Suppl
):
S8
14
.
6.
Hospers
JJ
,
Rijcken
B
,
Schouten
JP
,
Postma
DS
,
Weiss
ST
.
Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years
.
Am J Epidemiol
.
1999
;
150
:
482
91
.
7.
Diskin
CJ
,
Stokes
TJ
,
Dansby
LM
,
Radcliff
L
,
Carter
TB
.
The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service
.
Nephrol Dial Transplant
.
2011
;
26
(
8
):
2549
58
.
8.
Zhang
DL
,
Liu
J
,
Cui
WY
,
Ji
DY
,
Zhang
Y
,
Liu
WH
.
Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients
.
Ren Fail
.
2011
;
33
(
7
):
682
91
.
9.
Voudiklaris
S
,
Virvidakis
K
,
Kalmantis
T
,
Karafoulidou
A
,
Mountokalakis
T
.
Eosinophilia in patients undergoing regular hemodialysis
.
Int J Artif Organs
.
1983
;
6
(
4
):
195
8
.
10.
Hildebrand
S
,
Corbett
R
,
Duncan
N
,
Ashby
D
.
Increased prevalence of eosinophilia in a hemodialysis population: longitudinal and case control studies
.
Hemodial Int
.
2016
;
20
(
3
):
414
20
.
11.
Kang
DH
,
Lee
Y
,
Kleine
CE
,
Lee
YK
,
Park
C
,
Hsiung
JT
, et al.
Eosinophil count and mortality risk in incident hemodialysis patients
.
Nephrol Dial Transplant
.
2020 Jun 1
;
35
(
6
):
1032
42
.
12.
Jo
YI
,
Song
JO
,
Park
JH
,
Lee
JH
,
Shin
SK
.
Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement
.
Nephrology
.
2007
;
12
(
5
):
437
40
.
13.
Cho
Y
,
See
EJ
,
Htay
H
,
Hawley
CM
,
Johnson
DW
.
Early peritoneal dialysis technique failure: review
.
Perit Dial Int
.
2018
;
38
(
5
):
319
27
.
14.
Rubin
J
,
Rogers
WA
,
Taylor
HM
,
Everett
D
,
Prowant
BF
.
Peritonitis during continuous ambulatory peritoneal dialysis
.
Ann Intern Med
.
1980
;
92
:
7
13
.
15.
Htay
H
,
Johnson
DW
,
Wiggins
KJ
,
Badve
SV
,
Craig
JC
,
Strippoli
GF
, et al.
Biocompatible dialysis fluids for peritoneal dialysis
.
Cochrane Database Syst Rev
.
2018
;
10
:
CD007554
.
16.
Flessner
MF
,
Credit
K
,
Richardson
K
,
Potter
R
,
Li
X
,
He
Z
, et al.
Peritoneal inflammation after twenty-week exposure to dialysis solution: effect of solution versus catheter-foreign body reaction
.
Perit Dial Int
.
2010
;
30
(
3
):
284
93
.
17.
Humayun
HM
,
Ing
TS
,
Daugirdas
JT
,
Gandhi
VC
,
Popli
S
,
Robinson
JA
, et al.
Peritoneal fluid eosinophilia in patients undergoing maintenance peritoneal dialysis
.
Arch Intern Med
.
1981
;
141
(
9
):
1172
3
.
18.
Ohnmacht
C
,
Pullner
A
,
van Rooijen
N
,
Voehringer
D
.
Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity
.
J Immunol
.
2007
;
179
(
7
):
4766
74
.
19.
Ejaz
AA
,
Fitzpatrick
PM
,
Durkin
AJ
,
Wasiluk
A
,
Haley
WE
,
Goalen
MJ
, et al.
Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients
.
Nephron
.
1999
;
81
(
2
):
125
30
.
20.
Gauckler
P
,
Shin
JI
,
Mayer
G
,
Kronbichler
A
.
Eosinophilia and kidney disease: more than just an incidental finding?
J Clin Med
.
2018
;
7
(
12
):
529
.
21.
Nicod
LP
.
Cytokines I
.
Thorax
.
1993
;
48
:
660
7
.
22.
Robert
L
,
Bonnie
J
,
Stiehm
ER
.
Human eosinophils are more toxic than neutrophils in antibody-independent killing
.
J Allergy Clin Immunol
.
1991
;
87
:
1105
15
.
23.
Hogan
SP
,
Rosenberg
HF
,
Moqbel
R
,
Phipps
S
,
Foster
PS
,
Lacy
P
, et al.
Eosinophils: biological properties and role in health and disease
.
Clin Exp Allergy
.
2008
;
38
(
5
):
709
50
.
24.
Zhou
Q
,
Bajo
MA
,
del Peso
G
,
Yu
X
,
Selgas
R
.
Preventing peritoneal membrane fibrosis in peritoneal dialysis patients
.
Kidney Int
.
2016
;
90
(
3
):
515
24
.
25.
Ishii
R
,
Fujita
SI
,
Kizawa
S
,
Sakane
K
,
Morita
H
,
Ozeki
M
, et al.
Association between absolute blood eosinophil count and CKD stages among cardiac patients
.
Heart Vessels
.
2014
;
31
(
2
):
198
205
.
26.
Hartl
S
,
Breyer
MK
,
Burghuber
OC
,
Ofenheimer
A
,
Schrott
A
,
Urban
MH
, et al.
Blood eosinophil count in the general population: typical values and potential confounders
.
Eur Respir J
.
2020 May 14
;
55
(
5
):
1901874
.
27.
Asaba
J
,
Bandyopadhyay
M
,
Kindy
M
,
Dasgupta
S
.
Estrogen receptor signal in regulation of B cell activation during diverse immune responses
.
Int J Biochem Cell Biol
.
2015
;
68
:
42
7
.
28.
De Martinis
M
,
Sirufo
MM
,
Suppa
M
,
Di Silvestre
D
,
Ginaldi
L
.
Sex and gender aspects for patient stratification in allergy prevention and treatment
.
Int J Mol Sci
.
2020
;
21
(
4
):
1535
.
29.
Fan
J
,
Guo
Q
,
Zhou
Q
,
Yi
C
,
Lin
J
,
Mao
H
, et al.
Gender impact on baseline peritoneal transport properties in incident peritoneal dialysis patients
.
Int Urol Nephrol
.
2019
;
51
(
11
):
2055
61
.
30.
Davies
SJ
.
Peritoneal solute transport and inflammation
.
Am J Kidney Dis
.
2014
;
64
(
6
):
978
86
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.